Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Open accessThe DOI matches its Crossref record; 334 of the 340 references it cites were found in a registry or an index.
Abstract
Despite the significant decline in mortality, cardiovascular diseases are still the leading cause of death worldwide. Among them, myocardial infarction (MI) seems to be the most important. A further decline in the death rate may be achieved by the introduction of molecularly targeted drugs. It seems that the components of the PI3K/Akt signaling pathway are good candidates for this. The PI3K/Akt pathway plays a key role in the regulation of the growth and survival of cells, such as cardiomyocytes. In addition, it has been shown that the activation of the PI3K/Akt pathway results in the alleviation of the negative post-infarct changes in the myocardium and is impaired in the state of diabetes. In this article, the role of this pathway was described in each step of ischemia and subsequent left ventricular remodeling. In addition, we point out the most promising substances which need more investigation before introduction into clinical practice. Moreover, we present the impact of diabetes and widely used cardiac and antidiabetic drugs on the PI3K/Akt pathway and discuss the molecular mechanism of its effects on myocardial ischemia and left ventricular remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the cardiovascular system, GLP-1 can reduce cardiac ischemia-reperfusion injury through the activation of specific signaling pathways, such as the PI3K/Akt pathway.437,438”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [437]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Sun, L., Wang, H., Xu, D., Yu, S., Zhang, L., & Li, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.2004980 · Cited by 136 · cited 1×
“[102] demonstrated in a cardiomyocyte (H9c2) cell culture that PI3K/Akt activation has a cardioprotective effect by reducing oxidative stress and inhibiting ferroptosis induced by doxorubicin (DOX) and lapatinib (LAP) [103,104].”
BackgroundRetractedSun, G., Lü, Y., Li, Y., Mao, J., Zhang, J., Jin, Y., Li, Y., Sun, Y., Liu, L., & Li, L. (2017) · Bioscience Reports · doi:10.1042/bsr20170899 · Cited by 36 · cited 1×
“miR-19 MiR-19a protects H9C2 cardiomyocytes against H/R-induced apoptosis by inhibiting PTEN [292]; MiR-19b promotes NRCFs proliferation and migration by targeting PTEN [293].”
BackgroundRetractedZhang, Z.-W., Li, H., Cui, Z., Zhou, Z., Chen, S., Ma, J., Hou, L., Pan, X., & Li, Q. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1652630 · Cited by 24 · cited 1×
“miR-122 up [295,301] Aggravates oxygen–glucose deprivation and reperfusion apoptosis of H9C2 cardiomyocytes inhibiting AKT/GSK-3β/β-catenin and AKT/mTOR pathway signaling [302,303];”
BackgroundRetractedGong, L., Chang, H. H., & Xu, H. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104325 · Cited by 9
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · cited 11×
“In turn, the overexpression of PTEN can be observed during MI, which inhibits the PI3K/Akt pathway and thus causes the opposite effect on IL-10, TNF-α, and MMP-2 expression, and in addition increases leukocyte infiltration in the myocardium and increases cardiomyocyte mortality.”
BackgroundInfluentialIbanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 2×
“observed that mTORC1 in vitro inhibits autophagosome formation by phosphorylation of unc-51-like autophagy activating kinase 1 (Ulk1) at Ser757 [186].”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 1×
“Autophagy is a lysosome-dependent process that utilizes double-membrane structures (autophagosomes) as a form of intracellular transport, and enables the cell to degrade and recycle its components [179,180].”
BackgroundAutophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Moreover, it ensures the availability of energy substrates and reduces oxidative stress that would otherwise promote cell death [177,178].”
BackgroundPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“Complete activation of Akt requires phosphorylation by PDK1 at the T308 site [33] and by the mammalian target of rapamycin complex 2 (mTORC2) [34,35] or DNA-dependent protein kinase (DNA-PK) [36] at the S473 site.”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 1×
“This prevents a caspase cascade, leading to cell death [64].”
BackgroundThe phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621 · cited 1×
“Activated PI3K phosphorylates the hydroxyl group in the third position of the inositol ring of phosphatidylinositol [31].”
BackgroundOverview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287 · cited 1×
“They can be transported to target cells by binding to proteins, including AGO, or within extracellular vesicles t(EVs) [267].”
BackgroundCollet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037 · cited 1×
“It involves the inflammation, fibrosis, and hypertrophy of the myocardium, and changes in the vascular bed and the conducive system of the heart [14,15].”
BackgroundOxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Libby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0106-z · Cited by 3,211
Role of C-Reactive Protein at Sites of Inflammation and Infection
Sproston, N. R., & Ashworth, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,029 · cited 5×
“C-reactive protein (CRP) is the most reactive serum protein of acute-phase inflammation and one of the most important prognostic biomarkers of atherosclerosis and cardiovascular disease (CVD) [150,151].”
BackgroundInfluentialPfeffer, M. A., & Braunwald, E. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,877 · cited 1×
“Such modifications occur initially as a consequence of the loss of a viable myocardium and abrupt increase in loading conditions [134].”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749 · cited 1×
“Receptor tyrosine kinases (RTKs) are surface receptors composed of three functional domains: an extracellular ligand-binding domain, a transmembrane domain and an intracellular tyrosine kinase domain [28].”
BackgroundMixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698 · cited 1×
“PI3K/Akt signaling appears to have a key role in promoting this process by phosphorylating and oligomerizing RIP1, RIP3, and MLKL in response to TNFα stimulation [93,94].”
BackgroundAutophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161 · cited 1×
“Post-infarction cardiac remodeling is a maladaptive, complex, and multifactorial process of regional and global structural and functional changes in the myocardium, and presents as a common complication of acute MI [16,131,132].”
BackgroundThe Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Mendoza, M. C., Er, E. E., & Blenis, J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.03.006 · Cited by 1,817
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767 · cited 2×
“Akt—protein kinase B, Bax—Bcl-2-associated X protein, Bcl-2—B-cell lymphoma 2, CMECs—cardiac microvascular endothelial cells, CREB—cAMP response element-binding pro- tein, ERK1/2—extracellular signal-regulated kinase1/2, FRS2—fibroblast growth factor receptor substrate 2, GSK-3β—glycogen synthase kinase 3 β, LV—left v…”
BackgroundRegulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735 · cited 20×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
BackgroundInfluentialThe PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
Production of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Yang, J., Nie, J., Ma, X., Wei, Y., Peng, Y., & Wei, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0954-x · Cited by 1,520 · cited 1×
“, LY294002) its activation are under investigation for oncology [44].”
BackgroundReed, G. W., Rossi, J. E., & Cannon, C. P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30677-8 · Cited by 1,507
Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000261924.76669.36 · Cited by 1,505 · cited 1×
“revealed that autophagy via Beclin-1 is particularly activated during reperfusion by the mass-produced ROS during that period [185].”
BackgroundMTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB
Martina, J. A., Chen, Y., Gucek, M., & Puertollano, R. (2012) · Autophagy · doi:10.4161/auto.19653 · Cited by 1,333 · cited 1×
“noticed, it has been observed to inhibit the transport of nuclear transcription factor EB (TFEB), a regulator of autophagy and lysosomal biogenesis, and thus downregulates the transcription of specific autophagy-related (Atg) genes [187].”
BackgroundPlasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322 · cited 1×
“PI3K/Akt signaling appears to have a key role in promoting this process by phosphorylating and oligomerizing RIP1, RIP3, and MLKL in response to TNFα stimulation [93,94].”
BackgroundPlasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.226357 · Cited by 1,283
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234 · cited 6×
“In addition, it is one of the key pathways in the loss of functional cardiomyocytes during MI [89,90].”
BackgroundInfluentialRegulation of the Inflammatory Response in Cardiac Repair
Frangogiannis, N. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.243162 · Cited by 1,194 · cited 2×
“Injury of the cardiac cells and the extracellular matrix due to acute ischemia provides a strong systemic inflammatory response associated with increased production of proinflammatory cytokines [143].”
BackgroundTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · cited 1×
“Therefore, Akt mediates diverse important cellular processes, including cell growth and proliferation, cell survival, and gene expression, as detailed in later sections of this article [37].”
BackgroundAnderson, J. L., & Morrow, D. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1606915 · Cited by 1,115
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062 · cited 1×
“Apart from mechanical interventions, certain groups of drugs, such as volatile anesthetics and G protein-coupled receptor (GPCR) agonists, can also initiate pharmacological IC [118].”
BackgroundInflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028 · cited 1×
“These cytokines released during MI affect both the area of necrosis and the surrounding tissues and determine the course of post-MI left ventricular remodeling [144].”
BackgroundWhitman, M., Downes, C. P., Keeler, M., Keller, T., & Cantley, L. (1988) · Nature · doi:10.1038/332644a0 · Cited by 1,016 · cited 1×
“PI3K was identified by Lewis Cantley’s group in 1988 [21], while Akt kinase was identified by Stephen Staal in 1987 [22].”
MethodYi, J., Zhu, J., Wu, J., Thompson, C. B., & Jiang, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017152117 · Cited by 974 · cited 2×
“indicated that PI3K/Akt signaling inhibits ferroptosis in cancer cells via a pathway consisting of mTOR complex 1 (mTORC1), sterol regulatory element-binding proteins 1 (SREBP1) and stearoyl-coenzyme A desaturase 1 (SCD1), where SCD1 finally leads to the production of monounsaturated fatty acids [107].”
BackgroundThe Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Lee, Y.-R., Chen, M., & Pandolfi, P. P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0015-0 · Cited by 917
Physiological and pathological cardiac hypertrophy
Shimizu, I., & Minamino, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.001 · Cited by 887 · cited 1×
“There are numerous triggers of cardiac hypertrophy, such as mechanical stress and humoral stimulation, which can lead to multiple metabolic responses [209].”
BackgroundThe PTEN–PI3K pathway: of feedbacks and cross-talks
Carracedo, A., & Pandolfi, P. P. (2008) · Oncogene · doi:10.1038/onc.2008.247 · Cited by 878 · cited 2×
“Another mechanism is dephosphorylation of Akt either at Thr308 by protein phosphatase 2A (PP2A) or at Ser473 by pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP) [46].”
BackgroundCardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872 · cited 1×
“Insulin promotes the protective cardiovascular endothelial functions by activating Akt, which then phosphorylates endothelial NO synthase (eNOS) in Ser1179, stimulating the production of cardioprotective NO [162].”
BackgroundGDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820 · cited 1×
“The key cytokine involved in sympathetic remodeling following MI is the nerve growth factor (NGF), part of the NGF/TrKA/PI3K/Akt pathway that regulates neuronal plasticity and survival [227,228].”
BackgroundStaal, S. P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5034 · Cited by 767 · cited 1×
“PI3K was identified by Lewis Cantley’s group in 1988 [21], while Akt kinase was identified by Stephen Staal in 1987 [22].”
MethodPI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Peng, Y., Wang, Y., Zhou, C., Mei, W., & Zeng, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.819128 · Cited by 763
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Abbate, A., Toldo, S., Marchetti, C., Kron, J., Van Tassell, B. W., & Dinarello, C. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.315937 · Cited by 730
Diabetes and mortality following acute coronary syndromes
Donahoe, S. M., Stewart, G. C., McCabe, C. H., Mohanavelu, S., Murphy, S. A., Cannon, C. P., & Antman, E. M. (2007) · JAMA · doi:10.1001/jama.298.7.765 · Cited by 716 · cited 1×
“Moreover, DM is associated with significantly higher mortality one year after ACS compared with non-DM patients, and this partially results from more severe damage of the myocardium [232].”
BackgroundFestjens, N., Vanden Berghe, T., & Vandenabeele, P. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.06.014 · Cited by 710
Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1
Kim, A. H., Khursigara, G., Sun, X., Franke, T. F., & Chao, M. V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.893-901.2001 · Cited by 709 · cited 6×
“This consequently suppresses the activity of c-Jun N-terminal kinase (JNK) and activating transcription factor 2 (ATF-2) in intact cells, which finally results in the inhibition of apoptosis induced by ASK1 [67].”
BackgroundInfluentialMatsui, T., Tao, J., del Monte, F., Lee, K.-H., Li, L., Picard, M., Force, T. L., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (2001) · Circulation · doi:10.1161/01.cir.104.3.330 · Cited by 701
Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) · Nature · doi:10.1038/nature04672 · Cited by 672 · cited 1×
“Importantly, apart from inflammation, CRP is also a mediator of inflammation with prothrombotic and proapoptotic properties [157,158], which further worsens the prognosis of patients.”
BackgroundRelationship Between Infarct Size and Outcomes Following Primary PCI
Stone, G. W., Selker, H. P., Thiele, H., Patel, M. R., Udelson, J. E., Ohman, E. M., Maehara, A., Eitel, I., Granger, C. B., Jenkins, P. L., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.069 · Cited by 669
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation · doi:10.1161/circulationaha.118.038010 · Cited by 658
Ferroptosis as a novel therapeutic target for cardiovascular disease
Wu, X., Li, Y., Zhang, S., & Zhou, X. (2021) · Theranostics · doi:10.7150/thno.54113 · Cited by 647
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
Roy, S., Khanna, S., Hussain, S.-R. A., Biswas, S., Azad, A., Rink, C., Gnyawali, S., Shilo, S., Nuovo, G. J., & Sen, C. K. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp015 · Cited by 614 · cited 3×
“Its inhibition results in elevated phosphorylation of Akt, which causes induction of matrix metalloprotease-2 (MMP-2) in cardiac fibroblasts in vitro [269].”
BackgroundHeart Failure After Myocardial Infarction: Incidence and Predictors
Jenča, D., Melenovský, V., Stehlik, J., Staněk, V., Kettner, J., Kautzner, J., Adámková, V., & Wohlfahrt, P. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13144 · Cited by 605 · cited 1×
“One of the main risk factors of post-MI HF development is diabetes mellitus (DM), which impairs cell communication, involving many molecular pathways including PI3K/Akt [20].”
BackgroundBolognese, L., Neskovic, A. N., Parodi, G., Cerisano, G., Buonamici, P., Santoro, G. M., & Antoniucci, D. (2002) · Circulation · doi:10.1161/01.cir.0000036014.90197.fa · Cited by 601 · cited 1×
“Post-infarction cardiac remodeling is a maladaptive, complex, and multifactorial process of regional and global structural and functional changes in the myocardium, and presents as a common complication of acute MI [16,131,132].”
BackgroundThe origin of fibroblasts and mechanism of cardiac fibrosis
Krenning, G., Zeisberg, E. M., & Kalluri, R. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22322 · Cited by 601 · cited 1×
“The replacement of the necrotic myocardium by connective tissue is the main mechanism of fibrosis during post-infarction left ventricular remodeling [200].”
BackgroundAdipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance
Deng, Z.-B., Poliakov, A., Hardy, R. W., Clements, R., Liu, C., Liu, Y., Wang, J., Xiang, X., Zhang, S., Zhuang, X., et al. (2009) · Diabetes · doi:10.2337/db09-0216 · Cited by 575 · cited 1×
“miR-155 up [313,314] Targets IKKi expression decreasing its cardioprotective role in activating Akt and NF-κB, independent of the PI3K, and enhances cardiac hypertrophy [315], inhibits the AKT/CREB pathway signal and impairs the left ventricle function [316].”
BackgroundOxidative stress injury in doxorubicin-induced cardiotoxicity
Songbo, M., Lang, H., Xinyong, C., Bin, X., Ping, Z., & Liang, S. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.02.013 · Cited by 566
The Role of Autophagy in the Heart
Sciarretta, S., Maejima, Y., Zablocki, D., & Sadoshima, J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121427 · Cited by 547
Schumacher, B., Pecher, P., von Specht, B. U., & Stegmann, T. (1998) · Circulation · doi:10.1161/01.cir.97.7.645 · Cited by 531
Jiang, B.-H., Zheng, J. Z., Aoki, M., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040560897 · Cited by 528
JNK-Mediated BIM Phosphorylation Potentiates BAX-Dependent Apoptosis
Putcha, G. V., Le, S., Frank, S., Besirli, C. G., Clark, K., Chu, B., Alix, S., Youle, R. J., LaMarche, A., Maroney, A. C., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00355-6 · Cited by 518
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction
Westman, P. C., Lipinski, M. J., Luger, D., Waksman, R., Bonow, R. O., Wu, E., & Epstein, S. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.073 · Cited by 506
Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2
Maejima, Y., Kyoi, S., Zhai, P., Liu, T., Li, H., Ivessa, A., Sciarretta, S., Del Re, D. P., Zablocki, D. K., Hsu, C.-P., et al. (2013) · Nature Medicine · doi:10.1038/nm.3322 · Cited by 499 · cited 1×
“Regulation of key proteins in this pathway has been shown to reduce infarct size [199].”
BackgroundCardiomyocyte death: mechanisms and translational implications
Chiong, M., Wang, Z. V., Pedrozo, Z., Cao, D. J., Troncoso, R., Ibacache, M., Criollo, A., Nemchenko, A., Hill, J. A., & Lavandero, S. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.130 · Cited by 491 · cited 1×
“Their activity determines the size of the infarcted area, and consequently, impairs the functions of the myocardium [48].”
BackgroundImpaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury
Ma, X., Liu, H., Foyil, S. R., Godar, R. J., Weinheimer, C. J., Hill, J. A., & Diwan, A. (2012) · Circulation · doi:10.1161/circulationaha.111.041814 · Cited by 491 · cited 1×
“Interestingly, Beclin 1 can both positively and negatively regulate autophagy, hence the optimum concentration range of this molecule is needed for autophagy to function efficiently [193].”
BackgroundIdentification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase
Feng, J., Park, J., Cron, P., Hess, D., & Hemmings, B. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406731200 · Cited by 488 · cited 2×
“Complete activation of Akt requires phosphorylation by PDK1 at the T308 site [33] and by the mammalian target of rapamycin complex 2 (mTORC2) [34,35] or DNA-dependent protein kinase (DNA-PK) [36] at the S473 site.”
BackgroundPGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH.
Kukreja, R. C., Kontos, H. A., Hess, M. L., & Ellis, E. F. (1986) · Circulation Research · doi:10.1161/01.res.59.6.612 · Cited by 487
Relationship Between Regional Cardiac Hyperinnervation and Ventricular Arrhythmia
Cao, J.-M., Fishbein, M. C., Han, J. B., Lai, W. W., Lai, A. C., Wu, T.-J., Czer, L., Wolf, P. L., Denton, T. A., Shintaku, I. P., et al. (2000) · Circulation · doi:10.1161/01.cir.101.16.1960 · Cited by 479 · cited 1×
“Such a sympathetic remodeling may cause electrophysiological disturbances and increased heterogeneity of noradrenergic transmission, and consequently increase the risk of dangerous arrhythmias [226].”
BackgroundThe Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Rai, S. N., Dilnashin, H., Birla, H., Singh, S. S., Zahra, W., Rathore, A. S., Singh, B. K., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0003-y · Cited by 478 · cited 1×
“PI3K/Akt signaling is essential for NGF and other neurotrophic activities [26].”
BackgroundMyocardial Infarction: Symptoms and Treatments
Lu, L., Liu, M., Sun, R., Zheng, Y., & Zhang, P. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0553-4 · Cited by 470
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
Shioi, T., McMullen, J. R., Tarnavski, O., Converso, K., Sherwood, M. C., Manning, W. J., & Izumo, S. (2003) · Circulation · doi:10.1161/01.cir.0000057979.36322.88 · Cited by 462 · cited 1×
“, with rapamycin) exacerbates cardiac dysfunction and dilation in the chronic phase of MI [197,198].”
BackgroundMetformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy
Yang, F., Qin, Y., Wang, Y., Meng, S., Xian, H., Che, H., Lv, J., Li, Y., Yu, Y., Bai, Y., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29680 · Cited by 461 · cited 1×
“Moreover, this antidiabetic drug can inhibit the expression of mTOR and reduce the activity of autophagy [260].”
BackgroundPost-Myocardial Infarction Heart Failure
Bahit, M. C., Kochar, A., & Granger, C. B. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2017.09.015 · Cited by 461
Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease
Sciarretta, S., Volpe, M., & Sadoshima, J. (2014) · Circulation Research · doi:10.1161/circresaha.114.302022 · Cited by 453 · cited 1×
“revealed that Akt phosphorylates diverse substrates during MI, indirectly causing forced activation of mTORC1 in the myocardium [184,188].”
BackgroundPathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
Phung, T. L., Ziv, K., Dabydeen, D., Eyiah-Mensah, G., Riveros, M., Perruzzi, C., Sun, J., Monahan-Earley, R. A., Shiojima, I., Nagy, J. A., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.003 · Cited by 438 · cited 2×
“In this case, PI3K/Akt increases angiogenesis, which was mentioned in the previous section, but these blood vessels are, however, unorganized and reminiscent of tumor vasculature [212].”
BackgroundAutophagy in chronically ischemic myocardium
Yan, L., Vatner, D. E., Kim, S.-J., Ge, H., Masurekar, M., Massover, W. H., Yang, G., Matsui, Y., Sadoshima, J., & Vatner, S. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506843102 · Cited by 430 · cited 1×
“also observed that in the pig heart, MI-induced autophagy could be a homeostatic mechanism which inhibits apoptosis and hence limits its destructive effects [182].”
BackgroundBernardo, B. C., Gao, X.-M., Winbanks, C. E., Boey, E. J. H., Tham, Y. K., Kiriazis, H., Gregorevic, P., Obad, S., Kauppinen, S., Du, X.-J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206432109 · Cited by 429 · cited 1×
“miR-34 up [294] Inhibition of miR-34a attenuates MI-induced LV remodeling in mice and induces Akt phosphorylation [298]; activates PI3K/AKT pathways via up-regulating ZEB1 in cardiomyocytes and attenuates hypoxia-induced injury [299]; protects H9C2 cardiomyocytes from high-glucose-induced injury [300].”
BackgroundMyocardial Fibrosis: Biomedical Research from Bench to Bedside
Gyöngyösi, M., Winkler, J., Ramos, I., Do, Q.-T., Firat, H., McDonald, K., González, A., Thum, T., Díez, J., Jaisser, F., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.696 · Cited by 397 · cited 1×
“These include excitation–contraction coupling and the systolic and diastolic function of the heart, which can lead to HF [201].”
BackgroundAbbate, A., Van Tassell, B. W., Biondi-Zoccai, G., Kontos, M. C., Grizzard, J. D., Spillman, D. W., Oddi, C., Roberts, C. S., Melchior, R. D., Mueller, G. H., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.287 · Cited by 393
The life of a cell: apoptosis regulation by the PI3K/PKB pathway
Duronio, V. (2008) · Biochemical Journal · doi:10.1042/bj20081056 · Cited by 390
Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
Gibb, A. A., & Hill, B. G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312017 · Cited by 387
Ezekowitz, J. A., Kaul, P., Bakal, J. A., Armstrong, P. W., Welsh, R. C., & McAlister, F. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.067 · Cited by 371
Linseman, D. A., Butts, B. D., Precht, T. A., Phelps, R. A., Le, S. S., Laessig, T. A., Bouchard, R. J., Florez-McClure, M. L., & Heidenreich, K. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2057-04.2004 · Cited by 370
The PI3K/AKT Pathway and Renal Cell Carcinoma
Guo, H., German, P., Bai, S., Barnes, S., Guo, W., Qi, X., Lou, H., Liang, J., Jonasch, E., Mills, G. B., et al. (2015) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.03.003 · Cited by 369 · cited 3×
“After bounding a ligand (growth factors (GFs), cytokines, hormones), RTK forms a dimer, which activates the intracellular domain and the mutual autophosphorylation of each monomer [29].”
BackgroundOrtega, F. J., Mercader, J. M., Moreno-Navarrete, J. M., Rovira, O., Guerra, E., Esteve, E., Xifra, G., Martínez, C., Ricart, W., Rieusset, J., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1847 · Cited by 362
Blume-Jensen, P., Janknecht, R., & Hunter, T. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70302-1 · Cited by 356 · cited 1×
“[70] revealed in cell line studies that PI3K/Akt can also regulate cell death of its downstream factors.”
BackgroundMTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
Zhang, D., Contu, R., Latronico, M. V. G., Zhang, J. L., Rizzi, R., Catalucci, D., Miyamoto, S., Huang, K., Ceci, M., Gu, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43008 · Cited by 337 · cited 1×
“, with rapamycin) exacerbates cardiac dysfunction and dilation in the chronic phase of MI [197,198].”
BackgroundRapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation
Bijur, G. N., & Jope, R. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02113.x · Cited by 331
Apoptosis in myocardial ischaemia and infarction
Krijnen, P. A. J., Nijmeijer, R., Meijer, C. J. L. M., Visser, C. A., Hack, C. E., & Niessen, H. W. M. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.11.801 · Cited by 328 · cited 1×
“Both the physical obstruction of a coronary vessel and the redistribution of blood flow reduce the oxygen supply and are responsible for irreversible damage of the cardiomyocytes [47].”
BackgroundEarly embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase
Bi, L., Okabe, I., Bernard, D. J., & Nussbaum, R. L. (2002) · Mammalian Genome · doi:10.1007/bf02684023 · Cited by 318 · cited 1×
“The lack of their expression leads to a blockade of cell division and embryonic lethality [23,24].”
BackgroundKologrivova, I., Shtatolkina, M., Suslova, T., & Ryabov, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664457 · Cited by 317
Qiao, L., Hu, S., Liu, S., Zhang, H., Ma, H., Huang, K., Li, Z., Su, T., Vandergriff, A., Tang, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123135 · Cited by 303 · cited 1×
“cle remodeling and decrease LVEF in mice 3 weeks after intramyocardial injection [277].”
BackgroundSciarretta, S., Zhai, P., Shao, D., Maejima, Y., Robbins, J., Volpe, M., Condorelli, G., & Sadoshima, J. (2012) · Circulation · doi:10.1161/circulationaha.111.078212 · Cited by 292 · cited 2×
“This sequence of events leads to the inhibition of autophagy and fiercely intensifies ischemic injury [184].”
BackgroundPreconditioning and postconditioning: United at reperfusion
Hausenloy, D. J., & Yellon, D. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.005 · Cited by 285 · cited 1×
“PI3K/Akt signaling is considered to be the main pro-survival kinase cascade mediating the IC-induced protective effect by forming a RISK pathway parallel to MEK1ERK1/2 [90,120].”
BackgroundUnderstanding myocardial infarction
Saleh, M., & Ambrose, J. A. (2018) · F1000Research · doi:10.12688/f1000research.15096.1 · Cited by 284 · cited 1×
“Cardiovascular diseases (CVD) are the leading cause of death globally, and myocardial infarction (MI) is of fundamental importance [1].”
BackgroundInhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.
Grünwald, V., deGraffenried, L. A., Russel, D., Friedrichs, W. E., Ray, R. B., & Hidalgo, M. M. (2002) · PubMed · Cited by 279
Role of PI3K/Akt signaling pathway in cardiac fibrosis
Qin, W., Cao, L., & Massey, I. Y. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04219-w · Cited by 277 · cited 2×
“It seems that they may be used as a part of antifibrotic therapy after MI, but the assessment of their safety and tolerance is needed [204].”
BackgroundSuleiman, M., Khatib, R., Agmon, Y., Mahamid, R., Boulos, M., Kapeliovich, M., Levy, Y., Beyar, R., Markiewicz, W., Hammerman, H., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.055 · Cited by 264
Preconditioning the Diabetic Heart
Tsang, A., Hausenloy, D. J., Mocanu, M. M., Carr, R. D., & Yellon, D. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2360 · Cited by 252
Kemi, O. J., Ceci, M., Wisloff, U., Grimaldi, S., Gallo, P., Smith, G. L., Condorelli, G., & Ellingsen, O. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21197 · Cited by 246 · cited 1×
“Nevertheless, long-term Akt activation induces pathological hypertrophy and HF [213].”
BackgroundMeng, S., Cao, J.-T., Zhang, B., Zhou, Q., Shen, C.-X., & Wang, C.-Q. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.04.003 · Cited by 245 · cited 1×
“Furthermore, miR-126 is downregulated in the EPCs from diabetic patients and impair their function by targeting SPRED1 and impairing Ras/ERK/VEGF and PI3K/Akt/eNOS signal pathways [281].”
BackgroundAngiogenesis in the Infarcted Myocardium
Cochain, C., Channon, K. M., & Silvestre, J.-S. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4849 · Cited by 244 · cited 2×
“As angiogenesis has such a cardioprotective potential in the early stages after MI, therapies focused on the PI3K/Akt pathway have become a novel treatment strategy for patients after infarction [217,222].”
BackgroundApoptosis Signal-Regulating Kinase 1 in Stress and Immune Response
Takeda, K., Noguchi, T., Naguro, I., & Ichijo, H. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094606 · Cited by 243 · cited 1×
“ASK1 is a mitogen-activated protein kinase (MAPK) and can be activated by multiple cytotoxic stressors [68].”
BackgroundC-reactive protein is a mediator of cardiovascular disease
Bisoendial, R. J., Boekholdt, S. M., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq238 · Cited by 232
Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status
Shiojima, I., Yefremashvili, M., Luo, Z., Kureishi, Y., Takahashi, A., Tao, J., Rosenzweig, A., Kahn, C. R., Abel, E. D., & Walsh, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204572200 · Cited by 222 · cited 1×
“Short-term activation of Akt promotes physiological hypertrophy, and despite leading to mild myocardial enlargement, it has a cardioprotective effect [211] by attenuating damage to ischemia in endothelial cells [212].”
BackgroundDistinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy
Chen, Y., Hua, Y., Li, X., Arslan, I. M., Zhang, W., & Meng, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00042 · Cited by 222 · cited 1×
“of autophagy may have a protective effect on the heart [194,195], which may be another potential target of the therapy.”
BackgroundDifferential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion
Zhai, P., Sciarretta, S., Galeotti, J., Volpe, M., & Sadoshima, J. (2011) · Circulation Research · doi:10.1161/circresaha.111.249532 · Cited by 218 · cited 1×
“Phosphorylation of GSK3β on a highly conserved N-terminal regulatory site at Ser9 contributes to both myocardial necrosis (by mitochondrial permeability transition pore (mPTP) opening) and apoptosis (via various mechanisms including phosphorylation of Bax and destabilization of pro-survival betacatenin) [74,75].”
BackgroundBuss, S. J., Muenz, S., Riffel, J. H., Malekar, P., Hagenmueller, M., Weiss, C. S., Bea, F., Bekeredjian, R., Schinke-Braun, M., Izumo, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.031 · Cited by 213 · cited 1×
“In addition, by regulation of autophagy and apoptosis, the activity of the PI3K/Akt/ mTOR pathway contributes to myocardial remodeling following MI [196].”
BackgroundBhamra, G. S., Hausenloy, D. J., Davidson, S. M., Carr, R. D., Paiva, M., Wynne, A. M., Mocanu, M. M., & Yellon, D. M. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-007-0691-y · Cited by 210 · cited 1×
“Furthermore, the addition of the PI3K inhibitor abolished the metformin-induced Akt phosphorylation and the protective effect [259].”
BackgroundAdverse Remodeling and Reverse Remodeling After Myocardial Infarction
Bhatt, A. S., Ambrosy, A. P., & Velazquez, E. J. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0876-4 · Cited by 210 · cited 1×
“This ultimately results in cardiac hypertrophy (CH) and heart failure (HF) [13,133].”
BackgroundFerroptosis: Opportunities and Challenges in Myocardial Ischemia‐Reperfusion Injury
Zhao, W.-K., Zhou, Y., Xu, T.-T., & Wu, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9929687 · Cited by 207
Tumor necrosis factor-mediated cell death: to break or to burst, that’s the question
Van Herreweghe, F., Festjens, N., Declercq, W., & Vandenabeele, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0283-0 · Cited by 205
Abbate, A., Biondi-Zoccai, G. G. L., Bussani, R., Dobrina, A., Camilot, D., Feroce, F., Rossiello, R., Baldi, F., Silvestri, F., Biasucci, L. M., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02959-5 · Cited by 203 · cited 1×
“Importantly, apart from inflammation, CRP is also a mediator of inflammation with prothrombotic and proapoptotic properties [157,158], which further worsens the prognosis of patients.”
BackgroundMechanism of Cardioprotection by Early Ischemic Preconditioning
Yang, X., Cohen, M. V., & Downey, J. M. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6236-x · Cited by 200 · cited 1×
“It plays a pivotal role as a mediator of IC and its pharmacological inhibition abolishes the infarct size either during the trigger phase or at reperfusion [123,124].”
BackgroundRecent advances in the diagnosis and treatment of acute myocardial infarction
Reddy, K. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i5.243 · Cited by 200 · cited 1×
“It results in the activation of many intracellular pathways which promotes the activation of programmed and unprogrammed cell death, leading to the impairment of cardiac functions [2,3].”
BackgroundGan, L., Xie, D., Liu, J., Bond Lau, W., Christopher, T. A., Lopez, B., Zhang, L., Gao, E., Koch, W., Ma, X.-L., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.042640 · Cited by 198 · cited 1×
“miR-130 up [295,309,310] Attenuates LV dysfunction and remodeling after MI targeting PTEN and increasing activity of Akt [311]”
BackgroundBoateng, S., & Sanborn, T. (2013) · Disease-a-Month · doi:10.1016/j.disamonth.2012.12.004 · Cited by 197 · cited 1×
“It results in the activation of many intracellular pathways which promotes the activation of programmed and unprogrammed cell death, leading to the impairment of cardiac functions [2,3].”
BackgroundSkinner, H. D., Zheng, J. Z., Fang, J., Agani, F., & Jiang, B.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404097200 · Cited by 192 · cited 1×
“Research shows that the downregulation of PTEN could promote angiogenesis through increasing the expression of VEGF as well as reinforcing the signal transduction of the VEGF-binding cell [220,221].”
BackgroundAKT Signalling in the Failing Heart
Chaanine, A. H., & Hajjar, R. J. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr080 · Cited by 185 · cited 1×
“The PI3K/Akt signaling pathway and its interaction with its downstream effectors are altered and play a key role in regulating this process [210].”
BackgroundSavoye, C., Equine, O., Tricot, O., Nugue, O., Segrestin, B., Sautière, K., Elkohen, M., Pretorian, E. M., Taghipour, K., Philias, A., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.011 · Cited by 183
Galluzzi, L., Berghe, T. V., Vanlangenakker, N., Büttner, S., Eisenberg, T., Vandenabeele, P., Madeo, F., & Kroemer, G. (2011) · International review of cytology · doi:10.1016/b978-0-12-386039-2.00001-8 · Cited by 181 · cited 20×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
InfluentialIdentification of a Role for the PI3K/AKT/mTOR Signaling Pathway in Innate Immune Cells
Xie, S., Chen, M., Yan, B., He, X., Chen, X., & Li, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094496 · Cited by 176 · cited 1×
“Moreover, the downexpression of the PI3K/Akt pathway can enhance the immune system activation [174,175].”
BackgroundEndothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates
Lee, M. Y., Luciano, A. K., Ackah, E., Rodriguez-Vita, J., Bancroft, T. A., Eichmann, A., Simons, M., Kyriakides, T. R., Morales-Ruiz, M., & Sessa, W. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408472111 · Cited by 176 · cited 1×
“Their expression varies between tissues and disease states [40,41].”
BackgroundMiki, T., Itoh, T., Sunaga, D., & Miura, T. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-67 · Cited by 173 · cited 1×
“Infarct size in animal models seems to be enlarged, however some results are contradictory [231].”
ResultOrn, S., Manhenke, C., Ueland, T., Damas, J. K., Mollnes, T. E., Edvardsen, T., Aukrust, P., & Dickstein, K. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp070 · Cited by 170 · cited 1×
“CRP concentration increases significantly in the first hours of MI [131,154], and its level is a clinically important predictor of the course of left ventricular remodeling and patient prognosis [155,156].”
BackgroundMayourian, J., Ceholski, D. K., Gorski, P. A., Mathiyalagan, P., Murphy, J. F., Salazar, S. I., Stillitano, F., Hare, J. M., Sahoo, S., Hajjar, R. J., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.312420 · Cited by 168 · cited 1×
“Moreover, mir-21 can be also transported inside EVs and therefore be a potential MI regenerative therapy target [276].”
BackgroundThe Dynamic Interplay Between Cardiac Inflammation and Fibrosis
Thomas, T. P., & Grisanti, L. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.529075 · Cited by 166
Mechanisms of lapatinib resistance in HER2-driven breast cancer
D’Amato, V., Raimondo, L., Formisano, L., Giuliano, M., De Placido, S., Rosa, R., & Bianco, R. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.08.001 · Cited by 164 · cited 3×
“For instance, Sun et al. [102] demonstrated in a cardiomyocyte (H9c2) cell culture that PI3K/Akt activation has a cardioprotective effect by reducing oxidative stress and inhibiting ferroptosis induced by doxorubicin (DOX) and lapatinib (LAP) [103,104].”
BackgroundPTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells
Ma, J., Sawai, H., Ochi, N., Matsuo, Y., Xu, D., Yasuda, A., Takahashi, H., Wakasugi, T., & Takeyama, H. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0154-x · Cited by 158
Li, S., Jia, W. P., Zhang, C., Li, X., Meng, W., Mo, X., Zhang, Q., Liu, Q., Ren, K., Du, R., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452512 · Cited by 157 · cited 1×
“miR-155 up [313,314] Targets IKKi expression decreasing its cardioprotective role in activating Akt and NF-κB, independent of the PI3K, and enhances cardiac hypertrophy [315], inhibits the AKT/CREB pathway signal and impairs the left ventricle function [316].”
BackgroundCardoso, R., Graffunder, F. P., Ternes, C. M. P., Fernandes, A., Rocha, A. V., Fernandes, G., & Bhatt, D. L. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100933 · Cited by 157 · cited 1×
“The administration of these drugs significantly reduces mortality among patients with HF, even without diabetes [264].”
BackgroundCardiac mTOR protects the heart against ischemia-reperfusion injury
Aoyagi, T., Kusakari, Y., Xiao, C.-Y., Inouye, B. T., Takahashi, M., Scherrer‐Crosbie, M., Rosenzweig, A., Hara, K., & Matsui, T. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00241.2012 · Cited by 152 · cited 1×
“Moreover, insulin can activate mTOR kinase, which may inhibit inflammation and fibrosis, responsible for adverse left ventricular remodeling and hemodynamic dysfunction [263].”
BackgroundElevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults
Wang, R., Hong, J., Cao, Y., Shi, J., Gu, W., Ning, G., Zhang, Y., & Wang, W. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0867 · Cited by 149 · cited 1×
“miR-122 up [295,301] Aggravates oxygen–glucose deprivation and reperfusion apoptosis of H9C2 cardiomyocytes inhibiting AKT/GSK-3β/β-catenin and AKT/mTOR pathway signaling [302,303];”
BackgroundPathophysiology of LV Remodeling in Survivors of STEMI
Carrick, D., Haig, C. E., Rauhalammi, S. M. O., Ahmed, N., Mordi, I. R., McEntegart, M. B., Petrie, M. C., Eteiba, H., Lindsay, M. M., Watkins, S., et al. (2015) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.03.007 · Cited by 148
Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS
Chatterjee, S., Browning, E. A., Hong, N., DeBolt, K., Sorokina, E. M., Liu, W., Birnbaum, M. J., & Fisher, A. B. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00298.2011 · Cited by 147
Cheng, S., Zhang, X., Feng, Q., Chen, J., Shen, L., Yu, P., Yang, L., Chen, D., Zhang, H., Sun, W., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.040 · Cited by 147 · cited 1×
“Moreover, overexpression of PTEN (PI3K/Akt inhibitor) attenuates these positive effects and, for example, inhibits angiogenesis and contributes to thrombosis by inducing endothelial dysfunction [218,219].”
BackgroundJansen, F., Wang, H., Przybilla, D., Franklin, B. S., Dolf, A., Pfeifer, P., Schmitz, T., Flender, A., Endl, E., Nickenig, G., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0367-8 · Cited by 140
Cai, Z. P., Parajuli, N., Zheng, X., & Becker, L. C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0277-1 · Cited by 139
Bellacosa, A., Testa, J. R., moore, R., & Larue, L. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.3.703 · Cited by 137 · cited 1×
“Its three isoforms are distinguished, namely Akt1, Akt2, and Akt3 (also known as PKBa, PKBb, and PKBc, respectively) [38,39].”
BackgroundInsulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress
Ji, L., Fu, F., Zhang, L., Liu, W., Cai, X., Zhang, L., Zheng, Q., Zhang, H., & Gao, F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00623.2009 · Cited by 135 · cited 1×
“In addition, it was observed that wortmannin (a PI3K inhibitor) can abolish this positive effect [261].”
BackgroundDiagnostic Value of Cell-free Circulating Micrornas for Obesity and Type 2 Diabetes: A Meta-analysis
Villard, A., & Marchand, L. (2015) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000251 · Cited by 133 · cited 1×
“miR-320 up [295,306] Increases vulnerability of cardiomyocytes to hypoxia/reoxygenation injury targeting expression of Akt3 [322].”
BackgroundFunaro, S., Torre, G. L., Madonna, M., Galiuto, L., Scarà, A., LABBADIA, A., Canali, E., Mattatelli, A., Fedele, F., Alessandrini, F., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn529 · Cited by 131
Tu, Y., Wan, L., Fan, Y., Wang, K., Bu, L., Huang, T., Cheng, Z., & Shen, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075872 · Cited by 126 · cited 1×
“Interestingly, inhibition of PTEN by miR-21 mediates the cardioprotective effect of ischemic postconditioning and results in alleviated myocardial apoptosis, decreased infarct size and improved left ventricle function in mice [274].”
BackgroundSun, D., Huang, J., Zhang, Z., Gao, H., Li, J., Shen, M., Cao, F., & Wang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033491 · Cited by 126 · cited 20×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
BackgroundInfluentialChoose Delicately and Reuse Adequately: The Newly Revealed Process of Autophagy
Kobayashi, S. (2015) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00096 · Cited by 125 · cited 1×
“Autophagy is a lysosome-dependent process that utilizes double-membrane structures (autophagosomes) as a form of intracellular transport, and enables the cell to degrade and recycle its components [179,180].”
BackgroundmTORC2 Regulates Cardiac Response to Stress by Inhibiting MST1
Sciarretta, S., Zhai, P., Maejima, Y., Del Re, D. P., Nagarajan, N., Yee, D., Liu, T., Magnuson, M. A., Volpe, M., Frati, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.010 · Cited by 122 · cited 1×
“Complete activation of Akt requires phosphorylation by PDK1 at the T308 site [33] and by the mammalian target of rapamycin complex 2 (mTORC2) [34,35] or DNA-dependent protein kinase (DNA-PK) [36] at the S473 site.”
BackgroundNagaoka, K., Matoba, T., Mao, Y., Nakano, Y., Ikeda, G., Egusa, S., Tokutome, M., Nagahama, R., Nakano, K., Sunagawa, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132451 · Cited by 121 · cited 1×
“The protective effect of this lipid-lowering drug was diminished by a PI3K/Akt pathway inhibitor (wortmannin) [78].”
BackgroundEffects of diet-induced obesity on inflammation and remodeling after myocardial infarction
Thakker, G. D., Frangogiannis, N. G., Bujak, M., Zymek, P., Gaubatz, J. W., Reddy, A. K., Taffet, G., Michael, L. H., Entman, M. L., & Ballantyne, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00322.2006 · Cited by 121 · cited 20×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
BackgroundInfluentialMarambio, P., Toro, B., Sanhueza, C., Troncoso, R., Parra, V., Verdejo, H., García, L., Quiroga, C., Munafo, D., Díaz-Elizondo, J., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.02.002 · Cited by 121
PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?
Mocanu, M. M., & Yellon, D. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707155 · Cited by 120 · cited 1×
“Preclinical studies show that this may play a crucial role in cardiac susceptibility to IRI and impaired cardioprotection in diabetic patients [235].”
BackgroundPhosphoinositide-Regulated Kinases and Phosphoinositide Phosphatases
Leslie, N. R., Biondi, R. M., & Alessi, D. R. (2001) · Chemical Reviews · doi:10.1021/cr000091i · Cited by 120 · cited 3×
“In the PI3K/Akt pathway, the 3-position PIP3 phosphate group can bind to both phosphoinositide-dependent kinase-1 (PDK1) and Akt (also known as PKB (protein kinase B)) and recruit the Akt protein in the cell membrane, enabling PDK1 to access the PKB [32].”
BackgroundMarso, S. P., Miller, T. D., Rutherford, B. D., Gibbons, R. J., Qureshi, M., Kalynych, A. M., Turco, M. A., Schultheiß, H., Mehran, R., Krucoff, M. W., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.02.080 · Cited by 117
Molecular Mechanisms of Sympathetic Remodeling and Arrhythmias
Gardner, R. T., Ripplinger, C. M., Myles, R. C., & Habecker, B. A. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.001359 · Cited by 117 · cited 1×
“Such arrhythmias are the result of sympathetic remodeling, a phenomenon of disturbance of the spatial distribution and density of the myocardial sympathetic innervation caused by denervation in the infarcted zone and hyperinnervation in the infarcted border zone [224,225].”
BackgroundRole of microRNA 21 in diabetes and associated/related diseases
Sekar, D., Venugopal, B., Sekar, P., & Ramalingam, K. (2016) · Gene · doi:10.1016/j.gene.2016.01.039 · Cited by 117
Chen, J., Gu, Z.-J., Wu, M., Yang, Y., Zhang, J., Ou, J., Zuo, Z., Wang, J., & Chen, Y. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0377-1 · Cited by 116
Shiomi, T., Tsutsui, H., Ikeuchi, M., Matsusaka, H., Hayashidani, S., Suematsu, N., Wen, J., Kubota, T., & Takeshita, A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00509-6 · Cited by 115
Hasan, R., Lasker, S., Hasan, A., Zerin, F., Zamila, M., Chowdhury, F. I., Nayan, S. I., Rahman, M. M., Khan, F., Subhan, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71449-1 · Cited by 111 · cited 1×
“showed that SGLT2 inhibitors can attenuate oxidative stress induced by isoprenaline by reducing inflammation [265].”
BackgroundZhang, L., Ouyang, P., He, G., Wang, X.-W., Song, D., Yang, Y.-J., & He, X.-J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16192 · Cited by 111 · cited 1×
“Furthermore, the above effects on angiogenesis may be also mediated by EVs-derived miR-126, and exosomes from miR-126overexpressing mesenchymal stem cells (MSCs) may be a promising therapeutic strategy to promote angiogenesis and wound repair [284].”
BackgroundMicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1
Liu, X., Xu, Y., Deng, Y., & Li, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489185 · Cited by 106 · cited 1×
“miR-223 up [310,317,318] Inhibits angiogenic function of CMECs by decreasing the PI3K/Akt signal activity [319], regulates cardiac hypertrophy by modulating the p-Akt activation [320], and mediates cardiac fibrosis after MI targeting RASA1 expression, which promotes MEK1/2, ERK1/2 and AKT phosphorylation [321].”
BackgroundThe Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment
Hu, H., Chen, Y., Jing, L., Zhai, C., & Shen, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.710963 · Cited by 106
Pyroptosis inhibition improves the symptom of acute myocardial infarction
Liu, W., Shen, J., Li, Y., Wu, J., Luo, X., Yu, Y., Zhang, Y., Gu, L., Zhang, X., Jiang, C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04143-3 · Cited by 105
Boras, E. A., SLEVIN, M. A., Alexander, M. Y., Aljohi, A. O., Gilmore, W., Ashworth, J., Krupiński, J., Potempa, L. A., Abdulkareem, I. A., El‐Obeid, A., et al. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.027 · Cited by 101 · cited 1×
“noted that CRP in combination with a Notch-3 activator promotes angiogenesis in bovine aortic endothelial cells via the PI3K/Akt pathway [159].”
BackgroundLiu, S.-X., Zhang, Y., Wang, Y.-F., Li, X.-C., Xiang, M., Bian, C., & Chen, P. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.03.033 · Cited by 99 · cited 2×
“Moreover, the use of the PI3K inhibitor LY2994002 abolished these positive effects [84,166,167].”
BackgroundMiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling
Chen, L., Wang, J., Wang, B., Yang, J., Gong, Z., Zhao, X., Zhang, C., & Du, K. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2567-9 · Cited by 99 · cited 19×
“The impact of the PI3K/Akt signal on the Notch1/Hes1 pathway and its beneficial effect on the diabetic myocardium after IRI was also presented by other researchers [240].”
BackgroundInfluentialGarikipati, V. N. S., Verma, S. K., Jolardarashi, D., Cheng, Z. A., Ibetti, J., Cimini, M., Tang, Y., Khan, M., Yue, Y., Benedict, C., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx052 · Cited by 99
Kale, J., Kutuk, O., Brito, G. C., Andrews, T. S., Leber, B., Letai, A., & Andrews, D. W. (2018) · EMBO reports · doi:10.15252/embr.201745235 · Cited by 99 · cited 1×
“Bax can also be phosphorylated at residue S184 directly by Akt, which inhibits its conformational change for mitochondrial membrane distribution [76,77].”
BackgroundFertin, M. J., Hennache, B., Hamon, M., Ennezat, P. V., Biausque, F., Elkohen, M., Nugue, O., Tricot, O., Lamblin, N., Pinet, F., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.071 · Cited by 98 · cited 1×
“CRP concentration increases significantly in the first hours of MI [131,154], and its level is a clinically important predictor of the course of left ventricular remodeling and patient prognosis [155,156].”
BackgroundIs autophagy associated with diabetes mellitus and its complications? A review
Bhattacharya, D., Mukhopadhyay, M., Bhattacharyya, M., & Karmakar, P. (2018) · EXCLI journal · doi:10.17179/excli2018-1353 · Cited by 98 · cited 1×
“of autophagy may have a protective effect on the heart [194,195], which may be another potential target of the therapy.”
BackgroundAKT2 Confers Protection Against Aortic Aneurysms and Dissections
Shen, Y. H., Zhang, L., Ren, P., Nguyen, M. T. H. D., Zou, S., Wu, D., Wang, X. L., Coselli, J. S., & LeMaire, S. A. (2012) · Circulation Research · doi:10.1161/circresaha.112.300735 · Cited by 97 · cited 1×
“Their expression varies between tissues and disease states [40,41].”
BackgroundAlegría, J. R., Miller, T. D., Gibbons, R. J., Yi, Q.-L., & Yusuf, S. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.06.020 · Cited by 96
Huang, Z., Wu, S., Kong, F., Cai, X., Ye, B., Shan, P., & Huang, W. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12990 · Cited by 95
Görenek, B., Lundqvist, C. B., Brugada, J., Camm, A. J., Hindricks, G., Huber, K., Kirchhof, P. F., Kück, K., Kudaiberdieva, G., Lin, T., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m08_19 · Cited by 95
Drenger, B., Ostrovsky, I. A., Barak, M., Nechemia-Arbely, Y., Ziv, E., & Axelrod, J. H. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31820efafd · Cited by 87 · cited 1×
“For example, activation of STAT3 is strongly reduced in STZ-induced diabetic rats, which results in the inhibition of PI3K/Akt activity and decreased cardioprotection [243].”
BackgroundCardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility
WANG, G., Bergman, M. R., NGUYEN, A., Turcato, S., Swigart, P. M., RODRIGO, M., Simpson, P. C., Karliner, J. S., Lovett, D., & Baker, A. J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.023 · Cited by 87 · cited 1×
“MMP-2 is involved in the remodeling of the extracellular matrix and may lead to the impaired ventricular contraction [270].”
BackgroundChen, L., Wang, X., Ha, T., Hu, Y., Liu, L., Zhang, X., Yu, H., Miao, J., Kao, R. L., Kalbfleisch, J. H., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.011 · Cited by 87 · cited 1×
“miR-130 up [295,309,310] Attenuates LV dysfunction and remodeling after MI targeting PTEN and increasing activity of Akt [311]”
BackgroundXue, R., Lei, S., Xia, Z., Wu, Y., Meng, Q., Zhan, L., Su, W., Liu, H., Xu, J., Liu, Z., et al. (2015) · Clinical Science · doi:10.1042/cs20150496 · Cited by 87 · cited 1×
“Moreover, selective inhibition of PTEN may preserve the cardioprotective effect of ischemic postconditioning in STZ-induced diabetic rats [246].”
BackgroundDoxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer
Wang, H., Li, F., Du, C., Wang, H., Mahato, R. I., & Huang, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400687w · Cited by 87 · cited 3×
“For instance, Sun et al. [102] demonstrated in a cardiomyocyte (H9c2) cell culture that PI3K/Akt activation has a cardioprotective effect by reducing oxidative stress and inhibiting ferroptosis induced by doxorubicin (DOX) and lapatinib (LAP) [103,104].”
BackgroundSimvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway
Chartoumpekis, D. V., Ziros, P. G., Psyrogiannis, A. I., Kyriazopoulou, V. E., Papavassiliou, A. G., & Habeos, I. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.117 · Cited by 86 · cited 1×
“Thus, regulation of the PI3K/Akt pathway can be used to reduce the inflammation and infiltration of the myocardium by immune cells, consequently improving post-MI left ventricular remodeling [176].”
MethodC‑reactive protein and cardiovascular disease: From animal studies to the clinic (Review)
Fu, Y., Wu, Y., & Liu, E. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8840 · Cited by 85 · cited 5×
“C-reactive protein (CRP) is the most reactive serum protein of acute-phase inflammation and one of the most important prognostic biomarkers of atherosclerosis and cardiovascular disease (CVD) [150,151].”
BackgroundInfluentialIschemic preconditioning and preinfarction angina in the clinical arena
Rezkalla, S. H., & Kloner, R. A. (2004) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0047 · Cited by 82 · cited 1×
“Moreover, exercise and pre-infarction angina can also promote transduction signals of IC, which can reduce infarct size and improve left ventricular function [119].”
BackgroundMicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy
Higashi, K., Yamada, Y., Minatoguchi, S., Baba, S., Iwasa, M., Kanamori, H., Kawasaki, M., Nishigaki, K., Takemura, G., Kumazaki, M., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00709.2014 · Cited by 81 · cited 3×
“Moreover, miR-145 promotes autophagy and reduces the infarct size in AMI models in vivo via targeting FRS2 (fibroblast growth factor receptor substrate (2) and activating the PI3K/Akt/mTOR pathway [286,287].”
BackgroundLiang, Y., Li, J., Xiao, H., He, Y., Zhang, L., & Yan, Y. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12643 · Cited by 81 · cited 2×
“miR-223 up [310,317,318] Inhibits angiogenic function of CMECs by decreasing the PI3K/Akt signal activity [319], regulates cardiac hypertrophy by modulating the p-Akt activation [320], and mediates cardiac fibrosis after MI targeting RASA1 expression, which promotes MEK1/2, ERK1/2 and AKT phosphorylation [321].”
BackgroundWnt signaling pathways in urological cancers: past decades and still growing
Majid, S., Saini, S., & Dahiya, R. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-7 · Cited by 79
Mailloux, R. J., Gardiner, D., & O’Brien, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.014 · Cited by 79
Wu, K., Yang, Y., Zhong, Y., Ammar, H. M., Zhang, P., Guo, R., Liu, H., Cheng, C., Koroscil, T. M., Chen, Y., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00056.2016 · Cited by 74
Research works printed but not linked: 1
- Yan, 2018, miRNA145 inhibits myocardial infarctioninduced apoptosis through autophagy via Akt3/mTOR signaling pathway in vitro and in vivo, Int. J. Mol. Med., 42, 1537
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“437,438 This involves modulating the cell apoptosis process, for example, by decreasing the Bax/Bcl-2 ratio in cardiomyocytes, reducing cytochrome C release, and caspase activation.”
BackgroundHypertensive heart disease: risk factors, complications and mechanisms
Masenga, S. K., & Kirabo, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1205475 · Cited by 216
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Wu, Z., Li, W., Jiang, K., Lin, Z., Qian, C., Wu, M., Xia, Y., Li, N., Zhang, H., Xiao, H.-X., et al. (2024) · MedComm · doi:10.1002/mco2.657 · Cited by 151
“158 Among them, the PH structural domain mediates the process of membrane translocation after AKT activation 159 ; the catalytic structural domain contains an ATP-binding site 160 ; and the C-terminal regulatory domain is proline-rich and contains another phosphorylation site, Ser473.”
BackgroundLiu, X., Li, D., Pi, W., Wang, B., Xu, S., Yu, L., Yao, L., Sun, Z., Jiang, J., & Mi, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109379 · Cited by 90
Song, M., Choi, D. B., Im, J. S., Song, Y. N., Kim, J. H., Lee, H., An, J., Kim, A., Choi, H. G., Kim, J., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06703-9 · Cited by 92
“…responses associated with IR injury and myocardial infarction [56] Thus, we presume that the increased population of endothelial cells in HOs may contribute to the more sensitive responses to hypoxia-induced apoptosis and the heightened production of in fl ammatory factors observed after IR injury.”
Background
Metadata
- Authors
- Walkowski, B., Kleibert, M., Majka, M., & Wojciechowska, M.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Kleibert, Marcin
- Majka, Miłosz
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-05-05
- Volume
- 11
- Issue
- 9
- Pages
- 1553
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9105930
- OpenAlex
- W4280571486
- Cited by
- 117
- References
- 340
- Citations by year
- 2026: 27 · 2025: 31 · 2024: 28 · 2023: 28 · 2022: 3
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Publishing Fund of the Medical University of Warsaw (1MA/N/2022)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PI3K/Akt signaling, myocardial ischemia, myocardial infarction, diabetic cardiomyopathy, diabetic heart, cardiomyocyte survival, molecularly targeted agents, antidiabetic drugs, cardiovascular drugs
- MeSH terms
- Diabetes Mellitus, Humans, Myocardial Infarction, Apoptosis, Phosphatidylinositol 3-Kinases, Ventricular Remodeling, Myocytes, Cardiac, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.